What are Ozempic and Mounjaro?
Both compounds are drugs used to keep blood sugar levels stable in adults with type 2 diabetes and must be supplied under a doctor’s prescription.
How do they act in the body?
Both semaglutide (Ozempic) and tirzepatide (Mounjaro) act on the hormone GLP-1, responsible for controlling anxiety and appetite. This helps in the weight loss process in overweight patients.
How are they supplied to the body?
The two medications are administered to the body through a pen-type injector, which can be filled with the necessary dose beforehand. This device allows the drug to be injected subcutaneously from the belly, arm or thigh.
What side effects do they have
The following list is the side effects that the two medications have in common.
- nausea
- vomiting
- diarrhea
- abdominal pain
- constipation
- heartburn
- burping
More serious side effects
In both cases, there is continuous pain that begins in the upper left part or in the center of the stomach, but can extend to the back, accompanied or not by vomiting.
Another effect to take into account is hypoglycemia (low blood sugar), which can be detected by dizziness or lightheadedness, blurred vision, anxiety, irritability, sweating, difficulty speaking. , hunger, confusion or drowsiness, tremors, weakness, headache or tachycardia.
Side effects of Ozempic
In addition to the effects mentioned, semaglutide has the risk of causing the following adverse effects.
- Rash; itching, swelling of the eyes, face, mouth, tongue, or throat; or difficulty breathing or swallowing
- Less frequent urination or swelling of the legs, ankles or feet due to fluid retention.
- Yellowing of the skin or eyes, fever, or clay-colored stools.
Side effects of Mounjaro
Although there are currently no more contraindications detected in this medication, it is possible that it has the same contraindications as Ozempic and that in the long term the adverse effects detected are the same.
On the other hand, if you detect any other symptoms, do not hesitate to contact your doctor or collaborate with the FDA through (http://www.fda.gov/Safety/MedWatch) or by calling 1-800-332-1088.
Medical prescription for Ozempic and Mounjaro
Both for both brands, as well as for generic drugs, which in this case are tirzepatide and semaglutide, a medical prescription is necessary. For US citizens, the process is simple, both through your doctor and through your health insurance.
There are various pages from which you can obtain all the necessary support in this regard.
Use of Mounjaro and Ozempic to lose weight
For some time now, the use of hormonal drugs has been widespread, in this case GLP-1 that works as appetite suppressants. This use should always be carried out under medical supervision.
The dangers of using glucagon-like peptide 1 (GLP-1)
Although their effectiveness in losing weight has been demonstrated, several laboratory studies already warn that semaglutide and tirzepatide could cause thyroid C cell tumors in humans. These are the most common symptoms:
- Appearance of a lump or swelling in the neck.
- Increased hoarseness when talking or sleeping.
- Increasing difficulty swallowing.
- In more acute cases, even difficulty breathing.
FAQs about Ozempic and Mounjaro
How much weight can I lose?
Can I use it if I don’t have type 2 diabetes?
Should I take it injected?
What happens if I want to stop taking the medication?
Does it work the same in men and women?
Conclusions on Mounjaro versus Ozempic
After following several specialized studies on both drugs, it can be seen that the two compounds act in a very similar way, with practically the same effects on people with obesity.
Use of semaglutide or tirzepatide on own initiative
Personally I would never recommend it. If you have accessed this website to find out about these drugs in order to carry out treatment on your own, simply put it out of your mind. Use these medications only if advised by a doctor.
Studies consulted
Although I have reviewed different studies to document in depth about each of the drugs, these are the ones that seemed most relevant to me:
- Semaglutide: an important advance in the pharmacological treatment of obesity. (Dr. Enrique Santas Olmeda)
- Patient Medication Information by AHFS [Internet]. Tirzepatide injection): American Society of Institutional Pharmacists, Inc.; ©2024. Protriptyline; [12/15/2023; consultation June 10 2024]; [approx. 5 p.]. Available at: https://medlineplus.gov/spanish/druginfo/meds/a622044-es.html
- Patient Medication Information by AHFS [Internet]. Tirzepatide injection): American Society of Institutional Pharmacists, Inc.; ©2024. Semaglutide; [12/15/2023;Revised document – 04/20/2024; consultation June 10 2024]; [approx. 5 p.]. Available at: https://medlineplus.gov/spanish/druginfo/meds/a618008-es.html
Remember that this is for informational purposes
The content of the Services, including text, graphics, images, links to third-party resources and other materials (“Content”), is for informational purposes only. The Services are not intended to be a substitute for medical advice, diagnosis or treatment. Always seek the advice of your physician or other qualified health provider when you have concerns regarding a medical condition.
User opinions and experiences
Currently you can evaluate the treatment if you have followed it and tell your experiences. I will post reviews submitted by real users after reviewing them. Remember that racist, xenophobic comments, insults or spam are not allowed. Your email will not be published in any case.
Hello, my name is Franc. Gayet and I am the author of this blog.
Since 2020 I have carried out more than a thousand reviews and comparisons of products, consulting all the data provided by the distribution companies and carrying out tests on them.
I have specialized in testing home, health and internet electronic products. I have configured and tested hundreds of gadgets for evaluation.
I also collaborate directly with users to resolve questions about the products, the purchasing processes and any problems they may have related to the evaluated products.
If you have any questions, do not hesitate to contact me or leave your question in the comments area.